Impax Labs Enters Commercialization Deal with Perrigo

Impax Laboratories, Inc.

today announced that it will collaborate with Perrigo Company

on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.